Stimulation of NTS A1 adenosine receptors differentially resets baroreflex control of regional sympathetic outputs

Am J Physiol Heart Circ Physiol. 2008 Jan;294(1):H172-82. doi: 10.1152/ajpheart.01099.2007. Epub 2007 Nov 2.

Abstract

Previously we showed that pressor and differential regional sympathoexcitatory responses (adrenal > renal >/= lumbar) evoked by stimulation of A(1) adenosine receptors located in the nucleus of the solitary tract (NTS) were attenuated/abolished by baroreceptor denervation or blockade of glutamatergic transmission in the NTS, suggesting A(1) receptor-elicited inhibition of glutamatergic transmission in baroreflex pathways. Therefore we tested the hypothesis that stimulation of NTS A(1) adenosine receptors differentially inhibits/resets baroreflex responses of preganglionic adrenal (pre-ASNA), renal (RSNA), and lumbar (LSNA) sympathetic nerve activity. In urethane-chloralose-anesthetized male Sprague-Dawley rats (n = 65) we compared baroreflex-response curves (iv nitroprusside and phenylephrine) evoked before and after bilateral microinjections into the NTS of A(1) adenosine receptor agonist (N(6)-cyclopentyladenosine, CPA; 0.033-330 pmol/50 nl). CPA evoked typical dose-dependent pressor and differential sympathoexcitatory responses and similarly shifted baroreflex curves for pre-ASNA, RSNA, and LSNA toward higher mean arterial pressure (MAP) in a dose-dependent manner; the maximal shifts were 52.6 +/- 2.8, 48.0 +/- 3.6, and 56.8 +/- 6.7 mmHg for pre-ASNA, RSNA, and LSNA, respectively. These shifts were not a result of simple baroreceptor resetting because they were two to three times greater than respective increases in baseline MAP evoked by CPA. Baroreflex curves for pre-ASNA were additionally shifted upward: the maximal increases of upper and lower plateaus were 41.8 +/- 16.4% and 45.3 +/- 8.7%, respectively. Maximal gain (%/mmHg) measured before vs. after CPA increased for pre-ASNA (3.0 +/- 0.6 vs. 4.9 +/- 1.3), decreased for RSNA (4.1 +/- 0.6 vs. 2.3 +/- 0.3), and remained unaltered for LSNA (2.1 +/- 0.2 vs. 2.0 +/- 0.1). Vehicle control did not alter the baroreflex curves. We conclude that the activation of NTS A(1) adenosine receptors differentially inhibits/resets baroreflex control of regional sympathetic outputs.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine / analogs & derivatives*
  • Adenosine / pharmacology
  • Adenosine A1 Receptor Agonists*
  • Adrenal Glands / drug effects
  • Adrenal Glands / innervation
  • Animals
  • Autonomic Fibers, Preganglionic / drug effects*
  • Autonomic Fibers, Preganglionic / metabolism
  • Baroreflex / drug effects*
  • Blood Pressure / drug effects
  • Dose-Response Relationship, Drug
  • Heart Rate / drug effects
  • Kidney / drug effects
  • Kidney / innervation
  • Lumbosacral Plexus / drug effects
  • Male
  • Neural Inhibition / drug effects*
  • Nitroprusside / pharmacology
  • Phenylephrine / pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • Receptor, Adenosine A1 / metabolism
  • Research Design
  • Solitary Nucleus / drug effects*
  • Solitary Nucleus / metabolism
  • Sympathetic Nervous System / drug effects*
  • Sympathetic Nervous System / metabolism
  • Vasoconstrictor Agents / pharmacology
  • Vasodilator Agents / pharmacology

Substances

  • Adenosine A1 Receptor Agonists
  • Receptor, Adenosine A1
  • Vasoconstrictor Agents
  • Vasodilator Agents
  • Nitroprusside
  • Phenylephrine
  • N(6)-cyclopentyladenosine
  • Adenosine